Formulation, Characterization and Physicochemical Evaluation of Ranitidine Effervescent Tablets

被引:40
作者
Aslani, Abolfazl
Jahangiri, Hajar
机构
[1] Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan, Iran
[2] Isfahan Univ Med Sci, Novel Drug Delivery Syst Res Ctr, Esfahan, Iran
关键词
Effervescent tablet; Ranitidine HCl; Fusion method; Direct compression method;
D O I
10.5681/apb.2013.051
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Purpose: The aim of this study was to design, formulate and physicochemically evaluate effervescent ranitidine hydrochloride (HCl) tablets since they are easily administered while the elderly and children sometimes have difficulties in swallowing oral dosage forms. Methods: Effervescent ranitidine HCl tablets were prepared in a dosage of 300 mg by fusion and direct compression methods. The powder blend and granule mixture were evaluated for various pre-compression characteristics, such as angle of repose, compressibility index, mean particle size and Hausner's ratio. The tablets were evaluated for post-compression features including weight variation, hardness, friability, drug content, dissolution time, carbon dioxide content, effervescence time, pH, content uniformity and water content. Effervescent systems with appropriate pre and post-compression qualities dissolved rapidly in water were selected as the best formulations. Results: The results showed that the flowability of fusion method is more than that of direct compression and the F-5 and F-6 formulations of 300 mg tablets were selected as the best formulations because of their physicochemical characteristics. Conclusion: In this study, citric acid, sodium bicarbonate and sweeteners (including mannitol, sucrose and aspartame) were selected. Aspartame, mint and orange flavors were more effective for masking the bitter taste of ranitidine. The fusion method is the best alternative in terms of physicochemical and physical properties.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 27 条
[1]
Bandeline FJ, 1989, PHARM DOSAGE FORMS T, P287
[2]
Basavaiah Kanakapura, 2005, ScienceAsia, V31, P207, DOI 10.2306/scienceasia1513-1874.2005.31.207
[3]
Bhardwaj V, 2010, AM EURAS J SCI RES, V5, P264
[4]
Bhushan YS, 2000, INDIAN DRUGS, V37, P312
[5]
BRUNTON LL, 2005, GOODMAN GILMANS PHAR
[6]
A multicentre comparative evaluation washable pants with an integral pad for light incontinence [J].
Clarke-O'Neill, S ;
Pettersson, L ;
Fader, M ;
Dean, G ;
Brooks, R ;
Cottenden, A .
JOURNAL OF CLINICAL NURSING, 2002, 11 (01) :79-89
[7]
Gosai A. R., 2008, INT J PHARM SCI NANO, V1, P106
[8]
Gunn C, 1986, COOPER GUNNS TUTORIA
[9]
Jaiswal D., 2009, INT J PHARM PHARM SC, V1, P128
[10]
Kitagami K, 1990, JPN GASTROENT, V87, P2025